Filing Details

Accession Number:
0001181431-11-047367
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-29 19:58:25
Reporting Period:
2011-08-25
Filing Date:
2011-08-29
Accepted Time:
2011-08-29 19:58:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1223697 M Don Bailey 1300 North Kellogg Drive
Suite D
Anaheim CA 92807
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-25 25,000 $1.74 124,500 No 4 M Indirect Held by the Bailey 1995 Family Trust
Common Stock Acquisiton 2011-08-25 5,000 $1.74 129,500 No 4 M Indirect Held by the Bailey 1995 Family Trust
Common Stock Disposition 2011-08-25 19,800 $26.04 109,700 No 4 S Indirect Held by the Bailey 1995 Family Trust
Common Stock Disposition 2011-08-25 10,200 $26.99 99,500 No 4 S Indirect Held by the Bailey 1995 Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Held by the Bailey 1995 Family Trust
No 4 M Indirect Held by the Bailey 1995 Family Trust
No 4 S Indirect Held by the Bailey 1995 Family Trust
No 4 S Indirect Held by the Bailey 1995 Family Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-08-25 25,000 $0.00 25,000 $1.74
Common Stock Stock Option (Right to Buy) Disposition 2011-08-25 5,000 $0.00 5,000 $1.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-05-17 No 4 M Indirect
5,000 2016-05-17 No 4 M Indirect
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.59-26.57, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 of the Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.635-$27.54, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 2 of the Form 4.
  3. Non-qualified stock options granted under the Queestcor Pharmaceuticals, Inc. 2004 Non-Employee Director Equity Incentive Plan on May 18, 2006.
  4. The option was fully vested and exercisable as of May 18, 2010.
  5. Non-qualified stock options granted under the Queestcor Pharmaceuticals, Inc. 2004 Non-Employee Director Equity Incentive Plan on May 18, 2006.
  6. The option was fully vested and exercisable on May 18, 2006, the date of grant.